About this event

American Neurological Association (ANA) Annual Meeting

1) Core event details (from official site content)

• Event title: American Neurological Association (ANA) Annual Meeting
• Event year: 2026
• Official website (source): https://2026.myana.org/
• Dates:
• Venue:
• City: San Diego
• Country: United States
• Event type (inferred from official pages): Annual scientific meeting with Continuing Medical Education (CME), abstracts (submission categories/fees/guidelines), exhibitors & sponsors, and specialty programming (e.g., ANA-NINDS Career Development Symposium, ANA Clinical Trials Course, and satellite symposium opportunities).

2) What kind of audience this event attracts (BUYERS / ATTENDEES)

ANA Annual Meeting is a neurology-focused professional and scientific gathering that draws a wide spectrum of decision-makers and influencers across academic neurology, clinical practice, research, and industry-sponsored medicine. While not a “sales floor only” conference, it does include exhibits and sponsorship, which typically means industry stakeholders actively participate to connect with neurologists, clinical researchers, and healthcare systems.

Main attendee groups (buyers and high-value attendees)

• Academic neurologists & department leadership (neurology chairs, division chiefs, program directors) who influence research priorities, clinical trial participation, and adoption of clinical protocols.
• Clinicians and fellowship trainees (neurology residents, fellows, early-career physicians) who shape long-term expertise and can be key opinion leaders within sub-specialties.
• Clinical researchers (investigators, translational researchers, neurometabolic and neuroimmunology-focused teams) who engage with trial design, endpoints, and evidence generation partners.
• Special symposium participants (including the ANA-NINDS Career Development Symposium) where career development and research networking create concentrated conversations around funding, mentorship, and trial pipelines.
• Industry buyers behind programs (medical affairs, HEOR/market access, clinical trial operations, neurology portfolio leadership) who need direct access to neurologists and research hubs.
• Digital/telemedicine and specialty care platform stakeholders when relevant (the official exhibitor list excerpt includes Access TeleCare, indicating that service models beyond pharma/device can participate).

What “buyer intent” looks like at this meeting

The “buyer” behavior here is usually not retail procurement; it is portfolio, evidence, and clinical collaboration. Sponsors and exhibitors typically seek:

• Relationships with neurologists for clinical trial awareness and investigator engagement
• Visibility among subspecialty leaders in rare disease, neurodegeneration, neuroimmunology, and related areas
• Opportunities to present or support education (aligned with the CME ecosystem)
• Learning about emerging science to inform pipeline and lifecycle strategy

3) Where the show is happening + attendee geographic origin

From the official site text provided, travel information explicitly references San Diego. The specific venue name and full address were not included in the snippet provided.

Location

• City: San Diego
• State/Region:
• Country: United States
• Venue:

Expected geographic origin of attendees (typical patterns for a national medical society meeting)

For a U.S.-based national neurology society annual meeting, attendee travel patterns generally cluster in:

• United States nationwide (major academic centers and community neurology groups)
• High density from research hubs (coasts and large metropolitan academic regions)
• Some international representation via research collaborations, visiting faculty, and industry global teams (even if the core base is U.S.-centric)

If we need to be exact on attendee origin distributions (e.g., percent West Coast vs. East Coast vs. international), we would confirm using event registration/travel reports or attendee profile summaries. The provided official snippet does not include those distribution metrics.

4) Audience reach (Local / National / Global)

ANA Annual Meeting is best characterized as a national reach event with industry and academic participation that can also bring global influence (through multinational medical education and global pharmaceutical/biotech teams).

• Local: Some attendees will come from the San Diego / Southern California region.
• National: Predominantly a U.S. audience of neurologists, researchers, trainees, and industry medical affairs/clinical teams.
• Global: Likely meaningful global presence from multinational companies and international research networks, but the core audience is U.S.-based.

5) Sample buyer company names (BUYERS ONLY) + websites

Below are example industry buyer organizations that commonly sponsor/exhibit at neurology and specialty medicine meetings. These are representative “buyer-like” targets for B2B attendee engagement and outreach planning. (If we receive the client’s product website, we can refine these to the best-matching specialties and buyers.)

Top 5 starter buyer targets to prioritize first (based on the official snippet visibility): Alexion, Access TeleCare, and then the next-tier neuroscience/neurology portfolio and medical affairs leaders from major pharma/biotech (e.g., Biogen, Genentech, Novartis). We can tighten the final list precisely once we receive the client product website.

6) Job profiles, industries & event type

Event type (structured)

• Scientific conference with abstract categories and an academic journal output pathway
• Continuing Medical Education (CME) environment
• Career development symposium (ANA-NINDS Career Development Symposium)
• Clinical trials education (ANA Clinical Trials Course)
• Exhibits and sponsor programs, including exhibitor table access within the main meeting space
• Satellite symposium opportunities (additional structured programming)

Job profiles to target (high likelihood of decision influence)

• Director/Head/VP, Medical Affairs (Neurology / Neuroscience / Specialty)
• Director/Head, Clinical Development (Neurology)
• Clinical Trials Lead (Operations, Program, or Strategy)
• Medical Science Liaison (MSL) Manager / Field Medical Lead
• Market Access / HEOR Director (for evidence and adoption)
• Clinical Education Director / Training & Engagement Lead
• Partnerships Director (Academic partnerships, clinical research networks)
• Digital Health / Telehealth Program Director (if product fits virtual care)
• Companion Diagnostics / Clinical Affairs Director (if product is diagnostics-related)
• Rare Disease Franchise / Portfolio Lead (where relevant to neuro rare conditions)

Industries to align with (from your provided industry list)

For ANA Annual Meeting, the most natural industry filters include:

• Pharmaceuticals
• Biotechnology
• Medical Devices
• Hospital & Health Care
• Health, Wellness & Fitness (only if the client product is wellness-adjacent, less typical for core neurology buyers)
• Information Technology & Services (for digital health platforms, evidence tools, or clinical workflow software)
• Internet (for telemedicine platform participation where applicable)
• Research (for clinical research services, trial networks, or evidence providers)
• Market Research (for HEOR, analytics, patient insights, and evidence strategy)
• Professional Training & Coaching (only where clinical education/training is the product core)
• Events Services (only if the client sells event-related services or education programs)

7) Estimated attendance (expected total footfall)

The provided official snippet includes exhibitor information and general meeting content, but it does not include an explicit “expected total attendance” number or floor/room footprint. Therefore, we cannot reliably state an exact attendance estimate from the text provided.

If we can access additional official pages (e.g., “About/Annual Meeting Overview” with attendance stats, or Exhibits & Poster Hall schedules with capacity notes), we can produce a better estimate. For now, we can still use decision-making proxies:

• Large number of CME and abstract-driven sessions typically correlates with meaningful participation across specialties
• Presence of exhibitors and sponsors indicates a B2B engagement zone with industry medical affairs teams
• Satellite symposia and specialty courses (clinical trials education, career development) concentrate specialized buyer interest

8) Key focus areas & buyer engagement

Key focus areas likely to draw sponsor/exhibitor buyers

• Cutting-edge clinical and basic neuroscience (academic sessions and abstracts)
• Education across career stages (trainee and early-career visibility, supported by the stated emphasis on diverse career stages)
• Clinical trials readiness and methodology (explicitly referenced: ANA Clinical Trials Course)
• Career development and research pathways (explicitly referenced: ANA-NINDS Career Development Symposium)
• Rare disease and neurologic conditions requiring specialized therapies (supported by featured sponsor positioning through rare disease-focused organizations)
• Specialty care delivery models (suggested by the inclusion of a telemedicine exhibitor with neurology among service lines)

Buyer engagement opportunities we would emphasize

• Exhibitor-facing networking around neurology subspecialty blocks and poster-related circulation
• Medical education alignment: co-presenting, supporting sessions, or engaging on CME-adjacent topics
• Clinical trials conversations: sponsor-side medical affairs teams frequently seek investigators and research leaders
• Rare disease outreach: targeted engagement for franchises where patient impact and evidence are core
• Digital and virtual care pilots: if the client product supports access, coverage, or specialty neurology telehealth pathways

Example engagement angle for outreach (what we would message)

We would frame the approach around: neurology education + clinical research connectivity + therapy and care delivery relevance. This makes outreach more valuable than generic conference attendance messaging, especially for medical affairs and clinical development buyers.

9) Client-product fit: “Who is buying attendee lists from us?” + best buyer recommendations (we need your website)

We can absolutely recommend the best matching buyers for ANA Annual Meeting based on your requirements—but we need your client product website first so we can map:

• Whether your product is pharma/biotech-facing, medical device/digital health, telemedicine/virtual care, clinical trials services, or education/CME support
• The best-fitting buyer job titles (medical affairs vs. clinical development vs. market access vs. clinical operations vs. partnerships)
• The best company types (rare disease franchise teams vs. broad neuroscience portfolios vs. service providers)

Please share your client website URL. After we review it, we will return:

• A refined “Top buyer set” for ANA 2026 (15–25 companies)
• Title-level targeting guidance aligned to your product category
• Recommended industry filters using your provided industry list
• A scoring/ranking rationale for why each buyer is a strong match

10) Practical next steps (what we need from you)

1. Client product website (required for #8 buyer matching refinement)
2. Your target buyer geography preference (U.S. only vs. global teams headquartered in the U.S.)
3. Whether the product is aimed at:
   • Pharma/biotech medical affairs & clinical development
   • Medical device/diagnostics clinical affairs
   • Hospitals, specialty clinics, or telehealth networks
   • Clinical trials outsourcing services (CRO/CTO)
   • Digital health platforms and evidence tools
4. Any compliance constraints (e.g., do-not-contact categories, regions, or title restrictions)

11) Summary: Is this event a good fit for attendee-driven B2B targeting?

Yes—ANA Annual Meeting is a strong event for B2B engagement because it concentrates:

• High relevance across neurology subspecialties
• A structured medical education environment (CME + courses)
• Clinical trials-oriented programming
• Observable sponsor/exhibitor participation (including rare disease and telemedicine stakeholders, based on the official snippet)
• A natural audience for medical affairs and clinical evidence conversations

Once we receive your client website, we will finalize the best buyer set (company + title) tailored specifically to your product requirements for ANA Annual Meeting 2026.